Skip to main content
Top
Published in: Inflammation 2/2015

01-04-2015

Ghrelin Attenuates Sepsis-Associated Acute Lung Injury Oxidative Stress in Rats

Authors: Mian Zeng, Wanmei He, Lijun Li, Bin Li, Liang Luo, Xubin Huang, Kaipan Guan, Weiling Chen

Published in: Inflammation | Issue 2/2015

Login to get access

Abstract

This study investigated the effect of ghrelin on oxidative stress in septic rat lung tissue. Male Sprague-Dawley rats were divided into sham-operation, sepsis, and ghrelin groups. Sepsis was induced by cecal ligation and puncture. Ghrelin was administered intraperitoneally at 3 and 15 h post-operation. Bronchoalveolar lavage was performed to collect alveolar macrophages (AMs). Inducible nitric oxide synthase (iNOS) messenger RNA (mRNA) expression in alveolar macrophages and iNOS protein levels were measured by reverse transcription PCR (RT-PCR) and Western blot. Pulmonary pathology was analyzed and nitrotyrosine expression was examined by immunohistochemistry. Plasma superoxide dismutase (SOD) and lung wet/dry weight were measured. In the sepsis group, iNOS mRNA expression in AMs was 1.33 ± 0.05, 1.44 ± 0.08, and 1.57 ± 0.11 at 6, 12, and 20 h post-surgery, respectively, and were higher compared with the sham-operation group (p < 0.05). No increase was observed at longer time points. iNOS mRNA expression in the sepsis group was lower compared with the ghrelin group (2.27 ± 0.37) (p < 0.05) at 20 h post-surgery. iNOS protein levels in the ghrelin group (0.87 ± 0.03, p < 0.05) were lower than in the sepsis group at 20 h. Ghrelin group pathological scores were lower than in the sepsis group (p < 0.05). Plasma SOD was slightly non-significantly decreased in the ghrelin group. No difference was observed in lung wet/dry weight ratios between sepsis and ghrelin groups. iNOS mRNA expression in AMs was elevated between 6 and 20 h after cecal ligation and puncture (CLP), but did not progress. Ghrelin attenuated pulmonary iNOS protein expression and tended to increase plasma SOD activity. Ghrelin suppressed pulmonary nitrosative stress in septic rats, but did not improve lung wet/dry weight ratios.
Literature
1.
go back to reference Kooy, N.W., J.A. Royall, Y.Z. Ye, D.R. Kelly, and J.S. Beckman. 1995. Evidence for in vivo peroxynitrite production in human acute lung injury. American Journal of Respiratory and Critical Care Medicine 151(4): 1250–4. doi:10.1164/ajrccm.151.4.7697261.PubMed Kooy, N.W., J.A. Royall, Y.Z. Ye, D.R. Kelly, and J.S. Beckman. 1995. Evidence for in vivo peroxynitrite production in human acute lung injury. American Journal of Respiratory and Critical Care Medicine 151(4): 1250–4. doi:10.​1164/​ajrccm.​151.​4.​7697261.PubMed
2.
go back to reference Chabot, F., J.A. Mitchell, J.M. Gutteridge, and T.W. Evans. 1998. Reactive oxygen species in acute lung injury. European Respiratory Journal 11(3): 745–57.PubMed Chabot, F., J.A. Mitchell, J.M. Gutteridge, and T.W. Evans. 1998. Reactive oxygen species in acute lung injury. European Respiratory Journal 11(3): 745–57.PubMed
5.
go back to reference Chen, J., X. Liu, Q. Shu, S. Li, and F. Luo. 2008. Ghrelin attenuates lipopolysaccharide-induced acute lung injury through NO pathway. Medical Science Monitor 14(7): R141–6. Chen, J., X. Liu, Q. Shu, S. Li, and F. Luo. 2008. Ghrelin attenuates lipopolysaccharide-induced acute lung injury through NO pathway. Medical Science Monitor 14(7): R141–6.
8.
go back to reference Hassett, P., G.F. Curley, M. Contreras, C. Masterson, B.D. Higgins, T. O’Brien, et al. 2011. Overexpression of pulmonary extracellular superoxide dismutase attenuates endotoxin-induced acute lung injury. Intensive Care Medicine 37(10): 1680–7. doi:10.1007/s00134-011-2309-y.PubMedCrossRef Hassett, P., G.F. Curley, M. Contreras, C. Masterson, B.D. Higgins, T. O’Brien, et al. 2011. Overexpression of pulmonary extracellular superoxide dismutase attenuates endotoxin-induced acute lung injury. Intensive Care Medicine 37(10): 1680–7. doi:10.​1007/​s00134-011-2309-y.PubMedCrossRef
13.
go back to reference Ware, L.B., and M.A. Matthay. 2001. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 163(6): 1376–83. doi:10.1164/ajrccm.163.6.2004035.PubMedCrossRef Ware, L.B., and M.A. Matthay. 2001. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. American Journal of Respiratory and Critical Care Medicine 163(6): 1376–83. doi:10.​1164/​ajrccm.​163.​6.​2004035.PubMedCrossRef
15.
go back to reference Wu, R., M. Zhou, X. Cui, H.H. Simms, and P. Wang. 2003. Ghrelin clearance is reduced at the late stage of polymicrobial sepsis. International Journal of Molecular Medicine 12(5): 777–81.PubMed Wu, R., M. Zhou, X. Cui, H.H. Simms, and P. Wang. 2003. Ghrelin clearance is reduced at the late stage of polymicrobial sepsis. International Journal of Molecular Medicine 12(5): 777–81.PubMed
16.
go back to reference Lu, M.C., T.A. Liu, M.R. Lee, L. Lin, and W.C. Chang. 2002. Apoptosis contributes to the decrement in numbers of alveolar macrophages from rats with polymicrobial sepsis. Journal of Microbiology, Immunology, and Infection 35(2): 71–7.PubMed Lu, M.C., T.A. Liu, M.R. Lee, L. Lin, and W.C. Chang. 2002. Apoptosis contributes to the decrement in numbers of alveolar macrophages from rats with polymicrobial sepsis. Journal of Microbiology, Immunology, and Infection 35(2): 71–7.PubMed
17.
go back to reference Sudar, E., B. Dobutovic, S. Soskic, V. Mandusic, Z. Zakula, M. Misirkic, et al. 2011. Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated rats. Journal of Physiology and Biochemistry 67(2): 195–204. doi:10.1007/s13105-010-0063-1.PubMedCrossRef Sudar, E., B. Dobutovic, S. Soskic, V. Mandusic, Z. Zakula, M. Misirkic, et al. 2011. Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated rats. Journal of Physiology and Biochemistry 67(2): 195–204. doi:10.​1007/​s13105-010-0063-1.PubMedCrossRef
18.
go back to reference Bonni, A., A. Brunet, A.E. West, S.R. Datta, M.A. Takasu, and M.E. Greenberg. 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286(5443): 1358–62.PubMedCrossRef Bonni, A., A. Brunet, A.E. West, S.R. Datta, M.A. Takasu, and M.E. Greenberg. 1999. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286(5443): 1358–62.PubMedCrossRef
19.
go back to reference Granado, M., J.A. Chowen, C. Garcia-Caceres, A. Delgado-Rubin, V. Barrios, E. Castillero, et al. 2009. Ghrelin treatment protects lactotrophs from apoptosis in the pituitary of diabetic rats. Molecular and Cellular Endocrinology 309(1–2): 67–75. doi:10.1016/j.mce.2009.06.006.PubMedCrossRef Granado, M., J.A. Chowen, C. Garcia-Caceres, A. Delgado-Rubin, V. Barrios, E. Castillero, et al. 2009. Ghrelin treatment protects lactotrophs from apoptosis in the pituitary of diabetic rats. Molecular and Cellular Endocrinology 309(1–2): 67–75. doi:10.​1016/​j.​mce.​2009.​06.​006.PubMedCrossRef
20.
go back to reference Rezaeian, F., R. Wettstein, C. Scheuer, K. Baumker, A. Bachle, B. Vollmar, et al. 2012. Ghrelin protects musculocutaneous tissue from ischemic necrosis by improving microvascular perfusion. American Journal of Physiology. Heart and Circulatory Physiology 302(3): H603–10. doi:10.1152/ajpheart.00390.2010.PubMedCrossRef Rezaeian, F., R. Wettstein, C. Scheuer, K. Baumker, A. Bachle, B. Vollmar, et al. 2012. Ghrelin protects musculocutaneous tissue from ischemic necrosis by improving microvascular perfusion. American Journal of Physiology. Heart and Circulatory Physiology 302(3): H603–10. doi:10.​1152/​ajpheart.​00390.​2010.PubMedCrossRef
Metadata
Title
Ghrelin Attenuates Sepsis-Associated Acute Lung Injury Oxidative Stress in Rats
Authors
Mian Zeng
Wanmei He
Lijun Li
Bin Li
Liang Luo
Xubin Huang
Kaipan Guan
Weiling Chen
Publication date
01-04-2015
Publisher
Springer US
Published in
Inflammation / Issue 2/2015
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9977-z

Other articles of this Issue 2/2015

Inflammation 2/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine